“`html
The CTO was enacted due to Xebra’s failure to file essential financial documents, including annual statements for the fiscal year ended February 28, 2025, and interim filings for Q1 2025. The company says it will retain its current name and trading symbol. New CUSIP (98402E305) and ISIN (CA98402E3059) numbers are assigned. Trading will remain halted until the required documents are filed and the BCSC lifts the CTO. This delay poses challenges for shareholders eager to realize their investments.
Il CTO è derivato dal mancato deposito dei documenti finanziari richiesti, includendo i bilanci annuali per l’anno chiuso al 28 febbraio 2025 e i rendiconti interimi per il primo trimestre 2025. La società manterrà il proprio nome e simbolo di negoziazione, con nuovi numeri CUSIP (98402E305) e ISIN (CA98402E3059) assegnati. Il trading rimarrà interrotto finché la società non presenterà i documenti richiesti e il CTO non sarà revocato.
El CTO se debió a la falta de presentación de los documentos financieros requeridos, incluyendo los estados anuales del año terminado el 28 de febrero de 2025 y los informes interinos del primer trimestre de 2025. La compañía mantendrá su nombre y símbolo de cotización actuales, con nuevos números CUSIP (98402E305) e ISIN (CA98402E3059) asignados. La negociación permanecerá detenida hasta que la empresa presente los documentos requeridos y se levante el CTO.
CTO는 2025년 2월 28일 종료 연도 및 2025년 1분기 중간 재무제표를 포함해 필요한 재무 문서를 제출하지 않은 데에서 비롯되었습니다. 회사는 현재의 이름과 거래 기호를 유지하지만 새로운 CUSIP(98402E305) 및 ISIN(CA98402E3059) 번호가 부여됩니다. 필요한 문서를 제출하고 CTO가 해제될 때까지 거래가 중단된 상태로 남습니다.
Le CTO résulte du fait que Xebra n’a pas déposé les documents financiers requis, notamment les états annuels pour l’exercice clos le 28 février 2025 et les comptes intermédiaires du premier trimestre 2025. La société conservera son nom et son symbole de cotation actuels, avec de nouveaux numéros CUSIP (98402E305) et ISIN (CA98402E3059) attribués. La négociation restera suspendue tant que les documents requis ne seront pas déposés et que le CTO ne sera levé.
Der CTO entstand durch das Versäumnis des Unternehmens, die erforderlichen Finanzunterlagen einzureichen, einschließlich der Jahresabschlüsse für das am 28. Februar 2025 endende Jahr und der Zwischenberichte für das erste Quartal 2025. Das Unternehmen behält seinen aktuellen Namen und Handelssymbol bei, erhält jedoch neue CUSIP-Nummer (98402E305) und ISIN (CA98402E3059). Der Handel bleibt ausgesetzt, bis die erforderlichen Dokumente eingereicht und der CTO aufgehoben wird.
نتيجة CTO هي فشل الشركة في تقديم الوثائق المالية المطلوبة، بما في ذلك القوائم السنوية للسنة المنتهية في 28 فبراير 2025 والتقارير المرحلية للربع الأول من 2025. ستحتفظ الشركة باسمها ورمز التداول الحاليين، مع منح أعداد CUSIP (98402E305) و ISIN (CA98402E3059) جديدة. سيظل التداول معلقاً حتى تقدم الشركة الوثائق المطلوبة وتُرفع CTO.
CTO 是因为公司未能提交所需的财务文件，包括截至2025年2月28日止年度报表以及2025年第一季度的中期报表。公司将维持其现有名称和交易代码，并分配新的CUSIP(98402E305)和ISIN(CA98402E3059)号码。只有公司提交所需文件并解除CTO，交易才会恢复。
Negative
- Company under cease trade order (CTO) for failing to file required financial documents
- Trading of shares suspended until regulatory compliance is achieved
- Significant share dilution with 10:1 consolidation ratio
09/12/2025 – 07:45 PM
VANCOUVER, BC / ACCESS Newswire / September 12, 2025 / Xebra Brands Ltd. (CSE:XBRA), a cannabis company with international aspirations, faces a critical juncture after announcing a 1-for-10 share consolidation slated for September 19, 2025. This move, while intended for strategic financial restructuring, is overshadowed by a cease trade order (CTO) issued by the British Columbia Securities Commission (BCSC) on September 3, 2025. The CTO stems from the company’s failure to file its annual financial statements for the year ended February 28, 2025, and interim financial statements for the quarter ended May 31, 2025.
From a financial engineering perspective, the share consolidation will reduce the number of outstanding shares to approximately 8,065,442. While the company anticipates no change to its name or trading symbol, new CUSIP and ISIN numbers will be assigned, marking a significant structural shift.
The implications of the CTO are multifaceted. From a compliance standpoint, Xebra must prioritize rectifying its regulatory shortcomings to regain investor trust and resume trading. From a market capitalization perspective, the reduced number of shares post-consolidation, juxtaposed with the CTO-induced trading halt, introduce uncertainty about future valuation. Investors are urged to closely monitor Xebra’s compliance initiatives and subsequent regulatory filings, as these developments will be instrumental in shaping the company’s near-term performance and long-term viability.
FAQ
What is the share consolidation ratio for Xebra Brands (CSE:XBRA)?
Xebra Brands will implement a 10:1 share consolidation, meaning shareholders will receive one new share for every ten shares currently held.
When will Xebra Brands’ share consolidation become effective?
The share consolidation will become effective on September 19, 2025, with a record date of September 22, 2025.
Why was a cease trade order issued for Xebra Brands?
The BCSC issued a cease trade order on September 3, 2025, due to Xebra’s failure to file annual financial statements for the year ended February 28, 2025, and Q1 2025 interim filings.
How many shares will Xebra Brands have outstanding after the consolidation?
Following the 1-for-10 consolidation, Xebra Brands will have approximately 8,065,442 common shares outstanding.
What are the new CUSIP and ISIN numbers for Xebra Brands shares?
The new CUSIP number will be 98402E305 and the new ISIN number will be CA98402E3059.
“`
Original article, Author: Jam. If you wish to reprint this article, please indicate the source:https://aicnbc.com/9253.html
